BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15045530)

  • 1. [Mandibular reconstruction with autologous bone and osseoinductive implant in the Göttingen minipig].
    Würzler KK; Heisterkamp M; Böhm H; Kübler NR; Sebald W; Reuther JF
    Mund Kiefer Gesichtschir; 2004 Mar; 8(2):75-82. PubMed ID: 15045530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of bone morphogenetic proteins in the treatment of clinical oral and maxillofacial osseous defects.
    Boyne PJ
    J Bone Joint Surg Am; 2001; 83-A Suppl 1(Pt 2):S146-50. PubMed ID: 11314792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconstruction of mandibular continuity defects with bone morphogenetic protein-2 (rhBMP-2).
    Herford AS; Boyne PJ
    J Oral Maxillofac Surg; 2008 Apr; 66(4):616-24. PubMed ID: 18355584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restoration of occlusal function using osseointegrated implants in the canine mandible reconstructed by rhBMP-2.
    Seto I; Tachikawa N; Mori M; Hoshino S; Marukawa E; Asahina I; Enomoto S
    Clin Oral Implants Res; 2002 Oct; 13(5):536-41. PubMed ID: 12453132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of rhBMP-2 on regeneration of buccal alveolar defects during the osseointegration of transgingival inserted implants.
    Smeets R; Maciejewski O; Gerressen M; Spiekermann H; Hanisch O; Riediger D; Blake F; Stein J; Hölzle F; Kolk A
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Oct; 108(4):e3-e12. PubMed ID: 19716715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Off-label use of recombinant human bone morphogenetic protein-2 (rhBMP-2) for reconstruction of mandibular bone defects in humans.
    Carter TG; Brar PS; Tolas A; Beirne OR
    J Oral Maxillofac Surg; 2008 Jul; 66(7):1417-25. PubMed ID: 18571026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional reconstruction of the non-human primate mandible using recombinant human bone morphogenetic protein-2.
    Marukawa E; Asahina I; Oda M; Seto I; Alam M; Enomoto S
    Int J Oral Maxillofac Surg; 2002 Jun; 31(3):287-95. PubMed ID: 12190136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior mandible (Type II bone) in dogs.
    Wikesjö UM; Xiropaidis AV; Qahash M; Lim WH; Sorensen RG; Rohrer MD; Wozney JM; Hall J
    J Clin Periodontol; 2008 Nov; 35(11):985-91. PubMed ID: 18976395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxymethylcellulose-stabilized collagenous rhOP-1 device-a novel carrier biomaterial for the repair of mandibular continuity defects.
    Wang H; Springer IN; Schildberg H; Acil Y; Ludwig K; Rueger DR; Terheyden H
    J Biomed Mater Res A; 2004 Feb; 68(2):219-26. PubMed ID: 14704963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of implants coated with recombinant human bone morphogenetic protein-2 and vacuum-dried using the critical-size supraalveolar peri-implant defect model in dogs.
    Decker JF; Lee J; Cortella CA; Polimeni G; Rohrer MD; Wozney JM; Hall J; Susin C; Wikesjö UM
    J Periodontol; 2010 Dec; 81(12):1839-49. PubMed ID: 20629551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone regeneration after topical BMP-2-gene delivery in circumferential peri-implant bone defects.
    Lutz R; Park J; Felszeghy E; Wiltfang J; Nkenke E; Schlegel KA
    Clin Oral Implants Res; 2008 Jun; 19(6):590-9. PubMed ID: 18422983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human bone morphogenetic protein 2 combined with an osteoconductive bulking agent for mandibular continuity defects in nonhuman primates.
    Herford AS; Lu M; Buxton AN; Kim J; Henkin J; Boyne PJ; Caruso JM; Rungcharassaeng K; Hong J
    J Oral Maxillofac Surg; 2012 Mar; 70(3):703-16. PubMed ID: 21549480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone formation at recombinant human bone morphogenetic protein-2-coated titanium implants in the posterior maxilla (Type IV bone) in non-human primates.
    Wikesjö UM; Huang YH; Xiropaidis AV; Sorensen RG; Rohrer MD; Prasad HS; Wozney JM; Hall J
    J Clin Periodontol; 2008 Nov; 35(11):992-1000. PubMed ID: 18976396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human bone morphogenetic protein-2 stimulation of bone formation around endosseous dental implants.
    Cochran DL; Schenk R; Buser D; Wozney JM; Jones AA
    J Periodontol; 1999 Feb; 70(2):139-50. PubMed ID: 10102551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primate mandibular reconstruction with prefabricated, vascularized tissue-engineered bone flaps and recombinant human bone morphogenetic protein-2 implanted in situ.
    Zhou M; Peng X; Mao C; Xu F; Hu M; Yu GY
    Biomaterials; 2010 Jun; 31(18):4935-43. PubMed ID: 20346504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone regeneration by recombinant human bone morphogenetic protein-2 in rat mandibular defects. An experimental model of defect filling.
    Higuchi T; Kinoshita A; Takahashi K; Oda S; Ishikawa I
    J Periodontol; 1999 Sep; 70(9):1026-31. PubMed ID: 10505805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osseointegration of oxidized and turned implants in circumferential bone defects with and without adjunctive therapies: an experimental study on BMP-2 and autogenous bone graft in the dog mandible.
    Salata LA; Burgos PM; Rasmusson L; Novaes AB; Papalexiou V; Dahlin C; Sennerby L
    Int J Oral Maxillofac Surg; 2007 Jan; 36(1):62-71. PubMed ID: 17027235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuity resection of the mandible after ameloblastoma - feasibility of oral rehabilitation with rhBMP-2 associated to bovine xenograft followed by implant installation.
    Lustosa RM; Macedo Dde V; Iwaki LC; Tolentino Ede S; Hasse PN; Marson GB; Iwaki Filho L
    J Craniomaxillofac Surg; 2015 Oct; 43(8):1553-60. PubMed ID: 26190695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiographic analysis of regenerated bone around endosseous implants in the canine using recombinant human bone morphogenetic protein-2.
    Cochran DL; Nummikoski PV; Jones AA; Makins SR; Turek TJ; Buser D
    Int J Oral Maxillofac Implants; 1997; 12(6):739-48. PubMed ID: 9425754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronan supports recombinant human bone morphogenetic protein-2 induced bone reconstruction of advanced alveolar ridge defects in dogs. A pilot study.
    Hunt DR; Jovanovic SA; Wikesjö UM; Wozney JM; Bernard GW
    J Periodontol; 2001 May; 72(5):651-8. PubMed ID: 11394401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.